Bioprocessing or biotechnology is used in the production of pharmaceuticals, foods, flavours, fuels, and chemicals with the aid of a biocatalyst such as an enzyme, microorganisms, plant cell, or animal cell in a bioreactor. It also includes genetic engineering for the administration of plants, animals, and microorganisms such as yeasts, bacteria, and fungi.
Today's
bioprocessing is the base of different emerging industries and technologies, including the production of therapeutic stem cells, gene therapy vectors, and new vaccines. Advances in
bioprocessing is a special interest to the industry as it highly shortens the development timeline, improves the final product and increases the productivity of Bio-manufacturing facilities.
In this conference, leaders in biopharmaceutical production investigate the latest technologies and manufacturing strategies for next generation
biologics and advanced therapies. It will mainly focus on main challenges within the field, assessing innovative solutions such as continuous
bioprocessing, SUTs, data integrity, PAT and the implementation of industry 4.0, all of which aim to increase the efficiency and yield of therapeutic production whilst maintaining high quality standards.
This topic is very interesting and the need for
bioprocessing and biologics is growing fast worldwide. This international forum will have an emphasis on change, developments, improvements, new directions, and management of
biologics and
bio-processing with focus on technical rather than commercial achievements.
Meeting Summary
- Learn about biomanufacturing strategies to meet the needs of multiple modalities in biologics.
- Discover how high-performance simulation algorithms can optimise bioprocessing Operations.
- Learn about bioprocessing technologies in biorefinery for sustainable production of fuels, chemicals, and polymers.
- Understand biopharmaceutical manufacturing : 2022 Trends.
- Analyse the efficacy of adaptive immune- cell therapy in patients with advanced gastric cancer.
- Understand what the regulatory expectations and challenges are.
- Explore how you can continue the evolution of vaccine development and manufacturing for the future.
- Create a CMO selection process and criteria for successful project implementation.
- Explore the principles and practices of CMC analytics for cell and gene therapy.
Key Topics & Discussions
- Overview of bioprocessing and biologics.
- Bioprocessing technologies.
- New directions in bioprocess development and manufacturing.
- The role of bioprocessing in building a bioeconomy.
- Financing and investment for biologics.
- Bioprocessing - applications and case studies.
- Regulatory strategies for intensified and continuous processing.
- Digital transformation.
Key Learning Benefits
- Learn about biomanufacturing strategies to meet the needs of multiple modalities in biologics.
- Discover how high-performance simulation algorithms can optimise bioprocessing Operations.
- Learn about bioprocessing technologies in biorefinery for sustainable production of fuels, chemicals, and polymers.
- Understand biopharmaceutical manufacturing : 2022 Trends.
- Analyse the efficacy of adaptive immune- cell therapy in patients with advanced gastric cancer.
- Understand what the regulatory expectations and challenges are.
- Explore how you can continue the evolution of vaccine development and manufacturing for the future.
- Create a CMO selection process and criteria for successful project implementation
- Explore the principles and practices of CMC analytics for cell and gene therapy.
The international target audience will consist of:
- Biotech companies.
- Researchers from the academia and the industry.
- Large pharma with interest in biotech.
- Contract manufacturing organisations.
- Engineering houses and consultants.
- Process engineers and developers.
- Manufacturing and production managers.
- Procurement groups.
- Investment managers.
- Those working in technologies to scale up bioprocesses for biologics, vaccines, related species for clinical trials or scale-up to commercialization : Pharma 4.0, technical operations, technical development, biologics development, drug substance, quality, process development, and cell line development.
